3 results match your criteria: "Midwest Eye Institute and Indiana University Medical Center[Affiliation]"

Statin-associated myasthenia gravis: report of 4 cases and review of the literature.

Medicine (Baltimore)

March 2006

From Midwest Eye Institute and Indiana University Medical Center, Departments of Ophthalmology and Neurology (VP, A Kawasaki), Indianapolis, Indiana; Scott and White Eye Institute (KHS), Temple, Texas; and Tel Aviv Sourasky Medical Center, Department of Ophthalmology, Neuro-ophthalmology Unit (A Kesler), Tel Aviv, Israel.

A few recent individual case reports have suggested that a myasthenic syndrome may be associated with statin treatment, but this association is not well described. We report 4 patients who developed symptoms of myasthenia gravis within 2 weeks of starting treatment with a statin drug. In 1 case the drug appears to have exacerbated underlying myasthenic weakness, whereas in the other 3 cases, de novo antibody formation appears to be most likely.

View Article and Find Full Text PDF

Aim: To characterise the clinical findings and natural history of anterior visual pathway compression by dolichoectatic intracranial vessels.

Methods: A retrospective case review of patients evaluated in an outpatient neuro-ophthalmology clinic.

Results: 10 patients with this condition were identified.

View Article and Find Full Text PDF

Superior segmental optic nerve hypoplasia.

J Neuroophthalmol

June 2002

Midwest Eye Institute and Indiana University Medical Center, Department of Ophthalmology, Indianapolis 46280, USA.

A visually asymptomatic 27-year-old man was found to have inferior altitudinal visual field defects binocularly. Ophthalmoscopy revealed superior segmental optic pallor with superior nerve fiber layer atrophy, nicely highlighted in red-free photographs. The patient's mother had insulin-dependent diabetes mellitus.

View Article and Find Full Text PDF